Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nab-paclitaxel combinations in advanced TNBC
NCT04159142Phase 2Recruiting
- Sponsor
- The Fourth Hospital of Hebei Medical University
- Start
- Nov 2019
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel in triple-negative breast cancer (TNBC), sponsored by The Fourth Hospital of Hebei Medical University. Started Nov 2019; status: recruiting.
02
Drugs
paclitaxel
03
Conditions
triple-negative breast cancer (TNBC)
Beyond the preview
Go deeper on NCT04159142.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04159142.